Clinical trial
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That…
NCT00004895 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004895 |
|---|---|
| Title | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery |
| Official title | Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Constipation, Impaction, and Bowel Obstruction, Extrahepatic Bile Duct Cancer, Gastric Cancer, Gastrointestinal Stromal Tumor, Nausea and Vomiting, Ovarian Cancer, Pancreatic Cancer and 2 more |
| Intervention type | Drug |
| Interventions | octreotide acetate |
| Start date | Oct 1, 1999 |
| Primary completion | Oct 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | May 9, 2003 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: